Cocrystal Pharma, Inc (COCP) Stock Price

1.11 +0.00 (+0.00%)
Open: 1.138 Vol: 46.75K Day's range: 1.11 - 1.14 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
COCP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.12▼ 1.13▼ 1.13▼ 1.12▼ 1.04▲
MA10 1.13▼ 1.13▼ 1.14▼ 1.11▼ 1.03▲
MA20 1.14▼ 1.14▼ 1.14▼ 1.04▲ 1.14▼
MA50 1.13▼ 1.12▼ 1.09▲ 1.03▲ 1.42▼
MA100 1.11▲ 1.07▲ 1.06▲ 1.15▼ 1.68▼
MA200 1.06▲ 1.06▲ 1.07▲ 1.35▼ 2.34▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.005▼ -0.006▼ 0.010▲ 0.020▲
RSI 43.944▼ 46.199▼ 47.651▼ 57.078▲ 45.068▼
STOCH 18.750▼ 34.167     45.833     58.191     43.138    
WILL %R -100.000▼ -68.750     -68.750     -35.484     -47.103    
CCI -120.000▼ -109.511▼ -99.383     51.934     82.811    
Latest Filters Detected On COCP
▲ GAP $COCP Open Gap Up %2 Set Alert
CDL $COCP Matching Low Candlestick Pattern Detected Set Alert
Cocrystal Pharma, Inc News
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
Monday, January 12, 2026 12:14 AM
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
Monday, December 01, 2025 05:00 AM
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and ...
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Friday, November 14, 2025 05:00 AM
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatment Expects to initiate CDI-988 Phase 1b norovirus challenge study in Q1 2026 Granted NIH SBIR award to advance ...
COCP historical stock data
date open high low close volume
16/01/26 1.138 1.14 1.11 1.11 46,753
15/01/26 1.1711 1.1711 1.11 1.11 45,246
14/01/26 1.11 1.19 1.062 1.16 306,701
13/01/26 1.14 1.15 1.09 1.09 65,131
12/01/26 1.14 1.17 1.11 1.11 109,896
09/01/26 1.13 1.22 1.09 1.14 152,701
08/01/26 1.10 1.11 1.09 1.10 33,393
07/01/26 1.10 1.12 1.09 1.10 46,559
06/01/26 1.10 1.12 1.08 1.095 50,277
05/01/26 1.02 1.12 1.015 1.09 183,189
Quote Details
52wk Low:0.90
52wk High:2.67
Vol:46.75K
Avg Vol(3m):1.4M
1Y Chng:-42.19%
1M Chng:+7.25%
Add to Watch List
More Information
Index US Composite
Market Cap. 15.30M